Zacks Investment Research
23 Apr 2026, 13:45 UTC · 25w ago
ARS Pharmaceuticals, Inc. (SPRY) Soars 7.1%: Is Further Upside Left in the Stock?
Verdict
Headline takes no side. We score SPRY +0.80 — strongly bullish.
- Expected · SPRY
+0.80strongly bullish
−1 bearish0bullish +1More positive than 90% of ticker scores this week
- Actual





